Go to the list of all blogs
Anna G's Avatar
published in Blogs
Apr 14, 2023
TickeronGET DAILY SIGNALS
Expect Uptrend to Continue as Exact Sciences (EXAS, $67.02) Experiences Weekly Bullish Trend

Expect Uptrend to Continue as Exact Sciences (EXAS, $67.02) Experiences Weekly Bullish Trend

The rise of AI in the stock market has brought about new possibilities for traders and investors to make informed decisions. For EXAS, Tickeron's Earnings Trader (TA) bot has been one of the best performers in their robot factory. This particular bot is accessible through their website, and traders can use it to gain insights into potential trading opportunities. The bot leverages AI and technical analysis to provide recommendations for buying and selling EXAS stock.


As a technical analyst, it is important to stay up to date with the latest trends and signals in the stock market. In this article, we will take a closer look at Exact Sciences Corp (EXAS, $67.02) and its recent performance.

According to A.I.dvisor, EXAS is expected to experience a growth of 2% to reach $68.36 or more in the coming week. The stock has been on a winning streak for a consecutive week, and the odds of an Uptrend continuation are currently at 77%.

However, investors should be cautious as EXAS saw its Moving Average Convergence Divergence Histogram (MACD) turn negative on April 05, 2023. This indicates a bearish signal and suggests that the stock may decline going forward. Tickeron's A.I.dvisor has analyzed 47 instances where the MACD turned negative, and in 42 of those cases, the stock moved lower in the days that followed. This puts the odds of a downward move for EXAS at 89%.

While it is always important to be mindful of potential risks, it is worth noting that past performance does not assure future results. As such, investors should continue to monitor the market closely and make informed decisions based on current trends and signals.
If you're interested in stocks and want to stay ahead of the game, consider registering with us, click here. Our platform utilizes the power of AI to provide you with valuable insights and analysis, helping you make informed decisions when it comes to trading and investing. Don't miss out on this opportunity to take your stock market game to the next level. Register with us now and start making money!

Related Ticker: EXAS
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a developer of proprietary technologies for the detection of cancer

Industry MedicalSpecialties

Industry
Biotechnology
Address
5505 Endeavor Lane
Phone
+1 608 284-5700
Employees
6600
Web
https://www.exactsciences.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Analysts expect Q1 2026 revenue of approximately $8.5 billion, a roughly 5% increase from $8.1 billion in Q1 2025. Consensus adjusted earnings per share (EPS) forecast stands at $4.74, reflecting a potential decline from prior-year levels amid pricing pressures.
Analysts expect Q1 2026 adjusted EPS of around $1.61, down from prior year levels due to softer commodity prices. Consensus revenue forecast stands at approximately $14.5 billion, reflecting a year-over-year decline.